Clinical Trial Update: The Treatment of Ocular Adnexal Extranodal Marginal Zone B-cell Lymphoma by Orelabrutinib and Radiotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating orelabrutinib in combination with radiotherapy for ocular adnexal extranodal marginal zone B-cell lymphoma is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Adnexal Marginal Zone B-cell Lymphoma

Drugs mentioned

• Orelabrutinib (orelabrutinib)

Snippet

Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Conditions: Extranodal Marginal Zone B-cell Lymphoma | Phase 2 | Status: RECRUITING